Laboratoires Pierre Fabre SA - Company Profile
Powered by 
All the sales intelligence you need on Laboratoires Pierre Fabre SA in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Laboratoires Pierre Fabre SA fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Laboratoires Pierre Fabre SA.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Laboratoires Pierre Fabre SA patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP3710011A1 | Application | PENTACYCLISCHE TRITERPENE ZUR BEHANDLUNG EINER ORALEN ERKRANKUNG | A61K31/56 | September 23, 2020 |
| EP3288593A1 | Application | KONJUGAT VON MONOMETHYL AURISTATIN F UND TRASTUZUMAB UND DESSEN VERWENDUNG ZUR BEHANDLUNG VON KREBS | A61K47/6803; A61K47/6855; A61P35/00 | March 07, 2018 |
| EP3285774A1 | Application | VERWENDUNG VON (4-HYDROXY-2-METHYL-1,1-DIOXIDO-2H-BENZO[E] [1,2] THIAZIN-3-YL)(NAPHTHALEN-2-YL)METHANON ZUR VORBEUGUNG UND/ODER BEHANDLUNG VON NICHTALKOHOLISCHER STEATOHEPATITIS | A61K31/5415; A61K45/06; A61P1/00; A61P1/16; A61P3/06; A61P43/00 | February 28, 2018 |
| EP3277676A1 | Application | SUBSTITUIERTE CHINAZOLINDERIVATE ALS DNA-METHYLTRANSFERASE-INHIBITOREN | A61P35/00; C07D401/14 | February 07, 2018 |
| LT2989088T | Grant | DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS | A61K31/175; A61K31/337; A61K31/401; A61K31/4025; A61K31/427; A61K31/4439; A61K31/4745; A61K31/475; A61K31/513; A61K31/519; A61K31/704; A61K31/7048; A61K31/7068; A61K33/243; A61K38/05; A61K38/07; A61K38/08; A61K45/06; A61P35/00; A61P43/00; C07D207/08; C07D207/09; C07D401/12; C07D417/12; C07D417/14; C07K5/0205; C07K5/06043; C07K7/02 | January 10, 2018 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer